Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic manipulation of innate lymphoid cells.
Cobb LM, Verneris MR. Cobb LM, et al. JCI Insight. 2021 Mar 22;6(6):e146006. doi: 10.1172/jci.insight.146006. JCI Insight. 2021. PMID: 33749662 Free PMC article. Review.
Movement System Diagnosis: A Consensus-Based Position for Pediatric Movement Specialists.
Cobb LP, Shane KA, McGee PN, Nesbit C, Brennan E, Moore J, Girolami GL, Dannemiller L, Donaldson C, Boynewics K, Carey H, Chase KM, Hall A, Jones M, O'Shea RK, Zipp GP. Cobb LP, et al. Pediatr Phys Ther. 2025 Apr 1;37(2):257-264. doi: 10.1097/PEP.0000000000001186. Epub 2025 Feb 24. Pediatr Phys Ther. 2025. PMID: 39998003
Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression.
Asare A, Previs RA, Spinosa D, Fellman B, Scott AL, Mulder I, Mahmoud M, Enbaya A, Siedel JH, Cobb L, Soliman PT, Sood AK, Coleman RL, Secord AA, Westin SN. Asare A, et al. Among authors: cobb l. Gynecol Oncol. 2025 Mar;194:112-118. doi: 10.1016/j.ygyno.2025.02.015. Epub 2025 Feb 22. Gynecol Oncol. 2025. PMID: 39987772
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer.
Grisham R, Monk BJ, Van Nieuwenhuysen E, Moore KN, Fabbro M, O'Malley DM, Oaknin A, Thaker P, Oza AM, Colombo N, Gershenson D, Aghajanian CA, Choi CH, Lee YC, Mirza MR, Coleman RL, Cobb L, Harter P, Lustgarten S, Youssoufian H, Banerjee S. Grisham R, et al. Among authors: cobb l. Int J Gynecol Cancer. 2025 Jan 6:ijgc-2024-005919. doi: 10.1136/ijgc-2024-005919. Online ahead of print. Int J Gynecol Cancer. 2025. PMID: 39375168
Ending Trans Fat-The First-Ever Global Elimination Program for a Noncommunicable Disease Risk Factor: JACC International.
Steele L, Drummond E, Nishida C, Yamamoto R, Branca F, Parsons Perez C, Allemandi L, Arnanz L, Schoj V, Khanchandani HS, Bhardwaj S, Garg R, Frieden TR, Cobb LK. Steele L, et al. Among authors: cobb lk. J Am Coll Cardiol. 2024 Aug 13;84(7):663-674. doi: 10.1016/j.jacc.2024.04.067. J Am Coll Cardiol. 2024. PMID: 39111974 Free PMC article. Review.
413 results